296269-51-7 Usage
Molecular Structure
1H-Pyrazole-4-methanol,α-[3-(dimethylamino)propyl]-1,5-diphenylconsists of a pyrazole ring with a methanol group at the 4-position, a diphenyl group at the 1and 5-positions, and a propyl group with a dimethylamino substituent attached to the pyrazole ring.
Functional Groups
Contains an amine group (-NH2) and a methanol group (-OH) which are commonly found in drugs.
Unique Structure
The compound has a specific arrangement of a pyrazole ring, diphenyl groups, and a propyl group with a dimethylamino substituent.
Potential Applications
May have potential applications in pharmaceuticals due to the presence of functional groups and unique structure that may impart specific biological activities.
Further Research
Additional research and testing are required to determine the exact properties and potential uses of 1H-Pyrazole-4-methanol,α-[3-(dimethylamino)propyl]-1,5-diphenyl-.
Check Digit Verification of cas no
The CAS Registry Mumber 296269-51-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,9,6,2,6 and 9 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 296269-51:
(8*2)+(7*9)+(6*6)+(5*2)+(4*6)+(3*9)+(2*5)+(1*1)=187
187 % 10 = 7
So 296269-51-7 is a valid CAS Registry Number.
296269-51-7Relevant articles and documents
4-Dialkylamino-1-(5-substituted or unsubstituted 1-phenyl-1H-pyrazol-4-yl)butan-1-ols: synthesis and evaluation of analgesic, anti-inflammatory and platelet anti-aggregating activities
Menozzi, Giulia,Mosti, Luisa,Merello, Luisa,Piana, Antonietta,Armani, Ugo,Ghia, Marco,Angiola, Marianna,Mattioli, Francesca
, p. 219 - 226 (2000)
A number of 4-dialkylamino-1-(5-substituted or unsubstituted 1-phenyl-1H-pyrazol-4-yl)butan-1-ols 2a-n were synthesized and tested in vivo for anti-inflammatory and analgesic activities and in vitro for platelet anti-aggregating activity. Dimethylaminoderivatives 2b, e, g showed good analgesic activity; almost all of them had strong platelet anti-aggregating properties at a final concentration of 1x10-3 M; pyrazoles 2c, d, f-h showed weak anti-inflammatory activity. Copyright (C) 2000 Elsevier Science S.A.